These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


266 related items for PubMed ID: 9521758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
    de Beer TA, Louw AI, Joubert F.
    Bioorg Med Chem; 2006 Jul 01; 14(13):4433-43. PubMed ID: 16517168
    [Abstract] [Full Text] [Related]

  • 4. Is Plasmodium falciparum aldolase useful for rational drug design?
    Döbeli H, Itin C, Meier B, Certa U.
    Acta Leiden; 1991 Jul 01; 60(1):135-40. PubMed ID: 1820702
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characteristics of the Plasmodium falciparum PK5 ATP-binding site: implications for the design of novel antimalarial agents.
    Keenan SM, Welsh WJ.
    J Mol Graph Model; 2004 Jan 01; 22(3):241-7. PubMed ID: 14629982
    [Abstract] [Full Text] [Related]

  • 8. Crystal structure of S-adenosyl-L-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum.
    Tanaka N, Nakanishi M, Kusakabe Y, Shiraiwa K, Yabe S, Ito Y, Kitade Y, Nakamura KT.
    J Mol Biol; 2004 Oct 29; 343(4):1007-17. PubMed ID: 15476817
    [Abstract] [Full Text] [Related]

  • 9. Specificity and inhibitory activity of antibodies to Plasmodium falciparum aldolase.
    Srivastava IK, Schmidt M, Certa U, Döbeli H, Perrin LH.
    J Immunol; 1990 Feb 15; 144(4):1497-503. PubMed ID: 2406342
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific inhibition of the aspartate aminotransferase of Plasmodium falciparum.
    Wrenger C, Müller IB, Schifferdecker AJ, Jain R, Jordanova R, Groves MR.
    J Mol Biol; 2011 Jan 28; 405(4):956-71. PubMed ID: 21087616
    [Abstract] [Full Text] [Related]

  • 16. Crystal structure of a chimera of human and Plasmodium falciparum hypoxanthine guanine phosphoribosyltransferases provides insights into oligomerization.
    Gayathri P, Sujay Subbayya IN, Ashok CS, Selvi TS, Balaram H, Murthy MR.
    Proteins; 2008 Dec 28; 73(4):1010-20. PubMed ID: 18536021
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Binding of aldolase and glyceraldehyde-3-phosphate dehydrogenase to the cytoplasmic tails of Plasmodium falciparum merozoite duffy binding-like and reticulocyte homology ligands.
    Pal-Bhowmick I, Andersen J, Srinivasan P, Narum DL, Bosch J, Miller LH.
    mBio; 2012 Dec 28; 3(5):. PubMed ID: 22991428
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.